Equasens (EQS.PA) traded up 1.89 % during a 24 hours period ending at 09:50 PM Central Europe on Monday 26th. One Equasens stock can currently be bought for about EUR 29.6 on popular exchanges. Current supply of Equasens stocks is 15 mn. Equasens has a current market capitalization of EUR 445.6 mn and approximately EUR 841.3 k worth of Equasens was traded on exchanges in the last 24 hours. Since last month end, Equasens has traded 2.6 % up. Simple moving average of last 200 days is at EUR 35.31. The highest price of past 52 weeks was recorded at EUR 45.35 on 12/30/2025. 52 weeks low was at EUR 27.45 on 10/19/2026.
Here is how related stocks have performed in the past 24 hours:
Dbv (DBV.PA) traded down -2.33 % and now trades at EUR 1.79. Current market capitalisation for Dbv is EUR 508.4 mn.
Atos (ATO.PA) traded down -2.43 % and now trades at EUR 25.14. Current market capitalisation for Atos is EUR 459.8 mn.
Assystem (ASY.PA) traded down -0.44 % and now trades at EUR 33.9. Current market capitalisation for Assystem is EUR 498.6 mn. Current price/earnings ratio for Assystem is 66.5.
Groupe Crit (CEN.PA) traded up 1.76 % and now trades at EUR 46.6. Current market capitalisation for Groupe Crit is EUR 486.7 mn. Groupe Crit has a current price to earnings ratio of 14.12.
Quadient (QDT.PA) traded down -0.4 % and now trades at EUR 14.92. Current market capitalisation for Quadient is EUR 508.6 mn.
About Equasens
Pharmagest Interactive SA is a health technology company operating in the health care sector with its main base located in Villers-les-Nancy, France. The company specializes in developing and commercializing IT solutions for pharmacies and the pharmaceutical industry across Europe. Through four divisions - Pharmaceuticals Solutions Europe, Solutions for Health and Medico-Social Institutions, e-Health Solutions, and Fintech - it offers various products and services designed to cater to the needs of different stakeholders in the health care industry. These include LGPI, a pharmacy business management software; a range of SABCO software for Belgian pharmacies; OFFICINE 2016 flagship software for Luxembourgish pharmacies; OFFIDOSE 2.0, a pharmacy business management software; robotic solutions for pharmacies; TITAN software suite, which provides a complete circuit of drug in elderly housing establishments and day care centers for elderly people; connected, secure, patient-oriented solutions for healthcare professionals; observational tracking software; application services through mobile phone; DO-Pill, a connected pillbox that allows patients not to forget their treatment; and communicating services. Furthermore, the company offers leasing financing solutions for the tertiary sector and Leasa, a full Web computing gateway acting as a hub for accessing financial partners and managing sales financing processes. Equasens also provides IT equipment and services for pharmacy wholesalers and distributors. The company was founded in 1996 and is currently headquartered in Villers-les-Nancy, France. Equasens is a subsidiary of Marque Verte Sante. The company’s website is accessible under www.pharmagest.com , and its stock is traded on both the NYSE and the Euronext Paris stock exchange.